from 01.09.2015 until now
Moskva, Russian Federation
Ufa, Ufa, Russian Federation
Predmet. Sredi rasprostranennyh endokrinnyh patologiy v poslednie desyatiletiya na pervom meste stoit saharnyy diabet. Po dannym Vsemirnoy organizacii zdravoohraneniya, k 2030 godu v mire kolichestvo bol'nyh saharnym diabetom uvelichitsya do 366 mln chelovek. Giperglikemiya uvelichivaet rasprostranennost' vospalitel'nyh zabolevaniy slizistoy obolochki rta, vospalitel'nyh izmeneniy parodonta, utyazhelyaya techenie processa i snizhaya kachestvo lecheniya. V dannoy stat'e rassmatrivaetsya vliyanie vospalitel'nyh zabolevaniy slizistoy obolochki rta i glikemicheskogo kontrolya na urovni IL-1B v desnevoy zhidkosti u pacientov s saharnym diabetom 1 tipa. Cel'. Izuchenie vliyaniya tyazhesti vospalitel'nyh zabolevaniy slizistoy obolochki rta i glikemicheskogo kontrolya na urovni IL-1B v desnevoy zhidkosti u pacientov s saharnym diabetom 1 tipa. Metodologiya. V processe issledovaniya byli provedeny zabor plazmy krovi dlya opredeleniya urovney glikirovannogo gemoglobina, sobrany obrazcy desnevoy zhidkosti dlya opredeleniya urovney IL-1B u pacientov s saharnym diabetom 1 tipa, imeyuschih razlichnye zabolevaniya slizistoy obolochki rta. Rezul'taty. V rezul'tate provedennogo nami issledovaniya pokazano znachitel'noe uvelichenie urovney vospalitel'nogo mediatora IL-1B v desnevoy zhidkosti u pacientov s insulinozavisimym saharnym diabetom s zabolevaniyami slizistoy obolochki rta i yavleniyami hronicheskogo parodontita. Vyvody. Nashe issledovanie demonstriruet, chto giperglikemiya vliyaet na povyshenie urovnya vospalitel'nogo mediatora IL-1B v desnevoy zhidkosti, chto privodit k povysheniyu chastoty i tyazhesti vospalitel'nyh zabolevaniy slizistoy obolochki rta i vospalitel'nyh izmeneniy parodonta u pacientov s saharnym diabetom 1 tipa.
saharnyy diabet 1 tipa, interleykin-1b, zabolevaniya slizistoy obolochki rta, giperglikemiya
1. Sravnenie effektivnosti primeneniya specializirovannyh sredstv dlya provedeniya individual'noy gigieny polosti rta u pacientov s saharnym diabetom 2-go tipa / L.Yu. Orehova [i dr.] // Parodontologiya. - 2013. - T. 18, №4. - S. 7-11.
2. Sravnitel'naya ocenka effektivnosti primeneniya lechebno-profilakticheskih zubnyh past u pacientov s saharnym diabetom / L.Yu. Orehova [i dr.] // Nauchno-prakticheskiy zhurnal. - 2013. - S. 35-36.
3. Yanushevich, O.O. Stomatologicheskaya zabolevaemost' naseleniya Rossii / O.O. Yanushevich. - Moskva: MGMSU, 2015. - 212 s.
4. Osobennosti stomatologicheskogo statusa u pacientov s saharnym diabetom i beremennyh zhenschin / L.Yu. Orehova [i dr.] // Parodontologiya. - 2014. - №4. - S. 73.
5. Zheleznikova, G.F. Citokiny kak prediktory techeniya i ishoda infekciy / G.F. Zheleznikova // Citokiny i vospalenie. -
6. - T. 8, №1. - S. 10-17.
7. Kliniko-immunologicheskaya ocenka effektivnosti mestnogo primeneniya 8 %-go askorbata hitozana v kompleksnom lechenii bol'nyh generalizovannym parodontitom / P.V. Ivanov, N.V. Bulkina, I.V. Zudina, A.P. Vedyaeva, L.A. Zyul'kina // Izvestiya VUZov. Povolzhskiy region. Medicinskie nauki. - 2015. - №2 (34). - S. 68-74.
8. Mihal'chenko, V.F. Kliniko-immunologicheskaya ocenka effektivnosti primeneniya medikamentoznyh lechebno profilakticheskih kompleksov pri lechenii bol'nyh parodontitom legkoy stepeni tyazhesti / V.F. Mihal'chenko, M.S. Patrusheva, A.T. Yakovlev // Vestnik Volgogradskogo gosudarstvennogo universiteta. Seriya 11: Estestvennye nauki. - 2012. - №1 (3). - S. 32-36.
9. Lebedev, K.A. Immunnyy status v polosti rta: metodicheskie rekomendacii / K.A. Lebedev, Yu.M. Maksimovskiy. - Moskva, 2012. - 90 c.
10. Cutler C.W., Machen R.L., Jotwani R., Iacopino A.M. Heightened gingival inflammation and attachment loss in diabetics with hyperlipidemia. J. Periodontol, 2014, vol. 70, pp. 1313-1321.
11. Tsai C., Hayes C., Taylor G.W. Glycemic control of type 1 diabetes and severe periodontal disease in the adult population. Community Dent Oral Epidemiol, 2012, vol. 30, pp. 182-192.
12. Salvi G.E., Yalda B., Collins J.G. et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulindependent diabetes mellitus patients. J Periodontol, 2012, vol. 68, pp. 127-135.
